Using ibrutinib in earlier lines of treatment results in better outcomes for patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
作者信息
Woyach Jennifer, Tedeschi Alessandra, Munir Talha, Siddiqi Tanya, Hillmen Peter, Byrd John C, Ghia Paolo, Mulligan Stephen P, Dai Sandra, Amaya-Chanaga Carlos I, Dean James P, O'Brien Susan M, Barr Paul M
机构信息
Division of Hematology, Department of Internal Medicine, The Ohio State University Medical Center, Columbus, OH, USA.
Department of Hematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
出版信息
Leuk Lymphoma. 2021 Dec;62(13):3278-3282. doi: 10.1080/10428194.2021.1957871. Epub 2021 Aug 13.
Abstract
摘要
Zotero 插件